文献速递系统性红斑狼疮其他结缔组织病

神经精神性系统性红斑狼疮的相关领域与结局测量工具:一项系统文献综述

Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

结果显示所用工具覆盖除「社会/资源利用」外的所有核心领域,但工具异质性大且无高质量证据,提示需建立并验证核心领域集与结局测量工具。

要点

  • NPSLE结局测量工具异质性大,缺乏高质量证据支持其作为临床试验终点。
  • 现有工具覆盖OMERACT除「社会/资源利用」外的所有核心领域。
  • 最常见核心领域为「表现/异常」与「生活影响」,亟需统一核心领域集。

核心结论

  • NPSLE研究所用结局测量工具异质性大,且无高质量证据支持任何工具。
  • 需开发并进一步验证NPSLE核心领域集与结局测量工具以促进临床研究可比性。

研究设计与样本

  • 遵循PRISMA指南的系统文献综述,检索PubMed、Embase、PsycINFO、Cochrane Library及EULAR outcome measures library中1967至2020年英文文献。

主要发现

  • 纳入研究覆盖OMERACT定义的所有核心领域,但「社会/资源利用」领域未见涉及。
  • 「表现/异常」为核心领域中最常见者,涵盖实验室与仪器标志物、指数及神经精神维度共10个领域。
  • 「生活影响」核心领域涵盖躯体功能(患者与医生双视角)、疼痛及生活质量共7个领域。

关键数值与推荐

  • 所有领域与结局测量工具按OMERACT Filter 2.1进行特征化,考虑核心领域(表现/异常、生活影响、死亡/寿命、社会/资源利用)及背景因素。

临床怎么用

  • 临床研究中选用NPSLE结局测量工具时需注意现有工具异质性大且缺乏高质量证据支持。
  • 建议关注OMERACT核心领域框架,尤其「社会/资源利用」领域目前缺乏相应测量工具。

局限性

  • 原文未报告纳入研究的偏倚风险或证据质量分级的具体方法学细节。
  • 原文未报告各结局测量工具的具体性能数据或验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although neuropsychiatric involvement in SLE (NPSLE) is one of the most complex and troubling manifestations of the disease, validated outcome instruments to be used as sensitive endpoints in controlled clinical trials are lacking. We performed a systematic literature review (SLR) to identify outcome measurement instruments and domains used to assess NPSLE. METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were used. Articles available in English (1967-2020), listed in PubMed, Embase, PsycINFO, Cochrane Library and the EULAR outcome measures library were screened. All domains and outcome measurement instruments were characterized according to the OMERACT Filter 2.1, considering core areas (manifestations/abnormalities, life impact, death/lifespan, societal/resource use) and contextual factors. RESULTS: Of 3392 abstracts evaluated, 83 studies were included in the SLR (15 974 patients, females 89.9%). Eligible studies included domains and instruments pertinent to all core areas defined by the OMERACT, except for 'societal/resource use'. The most common core areas were 'manifestations/abnormalities', covering 10 domains pertinent to laboratory and instrumental markers, indexes and neuropsychiatric dimension (cognitive, neurologic and psychiatric field), and 'life impact', covering 7 domains related to physical function (from both the perspective of the patient and the physician), pain and quality of life. CONCLUSION: Our study revealed great heterogeneity in the instruments derived from populations with NPSLE and none of these had high-quality evidence. This supports the need to develop and further validate a core domain set and outcome measurement instruments to promote clinical research in this field, enhancing comparability across studies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Silvagni E, Chessa E, Bergossi F, et al. Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review. Rheumatology (Oxford). 2021. PMID: 33788917. doi:10.1093/rheumatology/keab324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。